Remote Monitoring of Heart Failure in Patients with Implantable Cardioverter-Defibrillators: Current Status and Future Needs

Remote Monitoring of Heart Failure in Patients with Implantable Cardioverter-Defibrillators: Current Status and Future Needs

The management of heart failure remains challenging despite evidence-based medical and pharmacological advances, especially in the ambulatory setting. There is an urgent need to develop strategies to reduce hospitalizations and readmission rates due to heart failure. Frequent monitoring of high-risk...

Full description

Bibliographic Details
Main Authors:	Dominic A. M. J. Theuns, Sumant P. Radhoe, Jasper J. Brugts
Format:	Article
Language:	English
Published:	MDPI AG 2021-05-01
Series:	Sensors
Subjects:	heart failure remote monitoring implantable cardioverter-defibrillator cardiac resynchronization therapy mortality hospitalization
Online Access:	https://www.mdpi.com/1424-8220/21/11/3763

Similar Items

Risk factors for the first and second inappropriate implantable cardioverter-defibrillator therapy
by: Nobuhiro Nishii, et al.
Published: (2021-06-01)

Prophylactic catheter ablation for ventricular tachycardia reduces morbidity and mortality in patients with implantable cardioverter–defibrillator devices
by: Shinichi Niwano, et al.
Published: (2013-12-01)

Implantable cardioverter defibrillator and cardiac resynchronization therapy use in New Zealand (ANZACS‐QI 33)
by: Fang Shawn Foo, et al.
Published: (2020-02-01)

Atrial signal amplitude predicts atrial high‐rate episodes in implantable cardioverter defibrillator patients: Insights from a large database of remote monitoring transmissions
by: Massimo Zecchin, et al.
Published: (2020-04-01)

Interventional challenges due to venous occlusion during cardiac resynchronization therapy in patients with prior cardioverter-defibrillator implantation: Case report
by: Veysel Kutay Vurgun, et al.
Published: (2016-07-01)

Implantation of a Resynchronization Implantable Cardioverter Defibrillator in a Patient with Persistent Left Superior Vena Cava
by: Dante Antonelli, et al.
Published: (2007-10-01)

A novel cause of inappropriate subcutaneous implantable cardioverter-defibrillator therapies after a generator change
by: Timothy M. Markman, MD, et al.
Published: (2021-08-01)

The Subcutaneous Implantable Cardioverter-Defibrillator: Not For All
by: Krishnakumar Nair, et al.
Published: (2014-07-01)

Remote Monitoring of Implantable Cardioverter Defibrillator
by: Dwight W. Reynolds, et al.
Published: (2006-10-01)

IMPLANTABLE CARDIOVERTER DEFIBRILLATORS ARE THE MAIN MODE FOR SUDDEN CARDIAC DEATH PREVENTION
by: L. A. Bokeria, et al.
Published: (2019-02-01)

Premature ventricular contractions in patients with an implantable cardioverter defibrillator cardiac resynchronization therapy device: Results from the UMBRELLA registry
by: Finn Akerström, et al.
Published: (2020-05-01)

Magnets and implantable cardioverter defibrillators: What′s the problem?
by: Yiliam F Rodriguez-Blanco, et al.
Published: (2013-01-01)

Subcutaneous implantable cardioverter-defibrillator placement in a patient with a preexisting transvenous implantable cardioverter-defibrillator
by: Mohammad-Ali Jazayeri, MD, et al.
Published: (2017-06-01)

Subcutaneous implantable cardioverter defibrillator: Where do we stand?
by: Arindam Pande, et al.
Published: (2016-01-01)

Under-Utilization of Implantable Cardioverter Defibrillators in Patients with Heart Failure - The Current State of Sudden Cardiac Death Prophylaxis
by: Jayasree Pillarisetti, MD, et al.
Published: (2015-01-01)

Utilization of Subcutaneous Cardioverter-Defibrillator in Poland and Europe–Comparison of the Results of Multi-Center Registries
by: Maciej Kempa, et al.
Published: (2021-07-01)

Intermuscular pocket for subcutaneous implantable cardioverter defibrillator: Single-center experience
by: Paola Ferrari, MD, et al.
Published: (2016-06-01)

Factors That Cause Concerns after Cardioverter Defibrillator Implantation
by: Olimpia Karczewska, et al.
Published: (2021-06-01)

Predictors of Mortality Amongst Recipients of Implantable Cardioverter Defibrillators for Secondary Prevention of Cardiac Arrest
by: Sunil K. Agarwal, et al.
Published: (2007-10-01)

The Subcutaneous Implantable Cardioverter-Defibrillator: A Practical Review and Real-World Use and Application
by: Mark E. Panna Jr, MD, FACC, FHRS, et al.
Published: (2016-02-01)

Assessment of the clinical benefits of remote monitoring of cardiac-implanted devices: A single-center study in Japan
by: Konomi Togo, et al.
Published: (2013-02-01)

Trends in the use of implantable cardioverter‐defibrillator and cardiac resynchronization therapy device in advancing age: Analysis of the Japan cardiac device treatment registry database
by: Hisashi Yokoshiki, et al.
Published: (2020-08-01)

Ventricular tachycardia detection with the subcutaneous implantable cardioverter-defibrillator: Tracing the cause of an absent tracing
by: Fadi Mansour, MD, et al.
Published: (2020-02-01)

Analysis of arrhythmic episodes in patients with implanted cardioverter defibrillators and a high risk of sudden cardiac death
by: A. S. Postol, et al.
Published: (2019-11-01)

Implantable cardioverter-defibrillator programming after first occurrence of ventricular tachycardia in the Multicenter Automatic Defibrillator Implantation Trial–Reduce Inappropriate Therapy (MADIT-RIT)Key Findings
by: Mehmet K. Aktas, MD, MBA, FHRS, et al.
Published: (2020-06-01)

An unusual cause of implantable cardioverter defibrillator malfunction: Twiddler syndrome
by: Ufuk Eryılmaz, et al.
Published: (2013-10-01)

Psychological Problems of Patients with Implantable Cardioverter Defibrillators in Baghdad City.
by: Bayda'a A. Kareem
Published: (2014-04-01)

Inhibition of pacing in a dependent patient with an implantable cardioverter-defibrillator and a left ventricular assist device
by: Michele Murphy, MD, et al.
Published: (2016-11-01)

Implantable Cardioverter‐Defibrillator Shocks During COVID‐19 Outbreak
by: Selçuk Adabag, et al.
Published: (2021-06-01)

Relation of multicenter automatic defibrillator implantation trial implantable cardioverter-defibrillator score with long-term cardiovascular events in patients with implantable cardioverter-defibrillator
by: Abdulkadir Uslu, et al.
Published: (2019-03-01)

Azygos Vein Lead Implantation For High Defibrillation Thresholds In Implantable Cardioverter Defibrillator Placement
by: Naga VA Kommuri, et al.
Published: (2010-01-01)

Aortic perforation due to cardiac resynchronisation therapy defibrillator lead placement: Case report and medicolegal considerations
by: Antonino M. Grande, MD, et al.
Published: (2015-12-01)

Cardiac rehabilitation in patients with pacemakers and implantable cardioverter defibrillators
by: Marie Christine Iliou, et al.
Published: (2016-10-01)

The contribution of implantable cardioverter defibrillators to systemic inflammation in heart failure patients
by: Ozcan Orscelik, et al.
Published: (2019-06-01)

Complications and Mortality of Single Versus Dual Chamber Implantable Cardioverter Defibrillators
by: Ataallah Bagherzadeh, et al.
Published: (2006-04-01)

Implantable cardioverter-defibrillator oversensing due to electric shock
by: Jurčević Ružica, et al.
Published: (2010-01-01)

Living With Implantable Cardioverter Defibrillator: A phenomenological Study
by: Mohammad Abbasi, et al.
Published: (2014-11-01)

Living With Implantable Cardioverter Defibrillator: A phenomenological Study
by: Mohammad Abbasi, et al.
Published: (2014-11-01)

Sex‐specific differences in outcome and risk stratification of ventricular arrhythmias in implantable cardioverter defibrillator patients
by: Anne‐Lotte C.J. van derLingen, et al.
Published: (2021-10-01)

INvestigation on Routine Follow-up in CONgestive HearT FAilure Patients with Remotely Monitored Implanted Cardioverter Defibrillators SysTems (InContact)
by: Claudius Hansen, et al.
Published: (2018-06-01)